Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Bronchogenic × exemestane × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 53 Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Granulosa cell tumor of the ovary 1 Endometrial Hyperplasia 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Carboplatin 7 pembrolizumab 4 Pemetrexed 4 Paclitaxel 4 Cisplatin 3 selpercatinib 2 pralsetinib 2 durvalumab 2 atezolizumab 2 Radiosurgery 2 Gemcitabine 2 taletrectinib 1 repotrectinib 1 ceralasertib 1 cemiplimab 1 Platinum Compounds 1 Nivolumab 1 Interleukin-15 1 Docetaxel 1 Blood Specimen Collection 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡